Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tolling for autoimmunity-prime time for 7.

Ann Marshak-Rothstein1

  • 1Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02215, USA.

Immunity
|September 19, 2006
PubMed
Summary

Self-antigens may act as self-adjuvants, driving autoimmune diseases. Toll-like receptors play a crucial role in systemic autoimmune conditions, as highlighted by recent research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial cell expression of STING<sup>V154M</sup>: Gain-of-function mutation delays the resolution of UVB-induced skin injury.

The Journal of investigative dermatology·2026
Same author

Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus.

Science translational medicine·2025
Same author

Endothelial Cell Expression of STING <sup>V154M</sup> Gain-of-Function Mutation Delays the Resolution of UVB-induced Skin Injury.

bioRxiv : the preprint server for biology·2025
Same author

Two distinct durable human class-switched memory B cell populations are induced by vaccination and infection.

Cell reports·2025
Same author

Nucleic acid triggers of autoimmunity and autoinflammation.

Current opinion in immunology·2025
Same author

IFNγ initiates TLR9-dependent autoimmune hepatitis in DNase II deficient mice.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Immunology
  • Autoimmunity
  • Molecular Biology

Background:

  • Autoimmune diseases are characterized by the immune system attacking self-antigens.
  • The precise mechanisms triggering consistent autoantibody targeting of specific self-antigens remain incompletely understood.

Discussion:

  • Self-antigens may possess adjuvant properties, promoting autoimmune responses.
  • Toll-like receptors (TLRs) are implicated in the pathogenesis of systemic autoimmune diseases.

Key Insights:

  • Two studies in Immunity investigate the role of TLRs in systemic autoimmunity.
  • These findings suggest TLRs contribute to the development and progression of autoimmune conditions.

Outlook:

  • Further research into self-adjuvants and TLRs could reveal novel therapeutic targets.
  • Understanding these pathways is critical for developing effective treatments for autoimmune diseases.

Related Experiment Videos